Cell Metab 29:10031011.e4 Romero R, Sayin VI, Davidson SM, Bauer MR, Singh SX, LeBoeuf SE, Karakousi TR, Ellis DC, Bhutkar A, Snchez-Rivera FJ, Subbaraj L, Martinez B, Bronson RT, Prigge JR, Schmidt EE, Thomas CJ, Goparaju C, Davies A, Dolgalev I, Heguy A, Allaj V, Poirier JT, Moreira AL, Rudin CM, Pass HI, Vander Heiden MG, Jacks T, Papagiannakopoulos T (2017) Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis
20 Bhargava R, Chasen M, Elten M, MacDonald N
They become a problem when they are the number a person budgets against
Its portfolio spans therapeutic areas such as oncology, cardiovascular care, dermatology, gastroenterology and pain management
It works by allowing water and fats to penetrate stool, making it softer and easier to pass